| # | Drug | Count |
|---|---|---|
| 0 | SILDENAFIL CITRATE | 391 |
| 1 | TADALAFIL | 277 |
| 2 | ASPIRIN | 140 |
| 3 | ASPIRIN 325 MG | 136 |
| 4 | ASPIRIN 81 MG | 136 |
| 5 | PREDNISONE | 123 |
| 6 | PANTOPRAZOLE | 111 |
| 7 | ROSUVASTATIN | 102 |
| 8 | ADALIMUMAB | 99 |
| 9 | RAMIPRIL | 99 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACLIDINIUM BROMIDE | 60 | 0.0094 |
| 1 | ACETYLCYSTEINE | 83 | 0.0086 |
| 2 | CICLESONIDE | 84 | 0.0061 |
| 3 | ALMOTRIPTAN | 6 | 0.0057 |
| 4 | SILDENAFIL CITRATE | 391 | 0.0031 |
| 5 | EFINACONAZOLE | 6 | 0.0031 |
| 6 | TADALAFIL | 277 | 0.0027 |
| 7 | TAMSULOSIN HYDROCHLORIDE | 55 | 0.0026 |
| 8 | MESALAMINE | 71 | 0.0025 |
| 9 | CEFIXIME | 6 | 0.0020 |
| # | Drug class | Count |
|---|---|---|
| 0 | Phosphodiesterase 5 Inhibitor [EPC] | 279 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 208 |
| 2 | Corticosteroid [EPC] | 204 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 158 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 142 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 136 |
| 6 | Angiotensin Converting Enzyme Inhibitor [EPC] | 99 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 93 |
| 8 | Calcium Channel Blocker [EPC] | 92 |
| 9 | Antidote [EPC] | 88 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Phosphodiesterase 5 Inhibitor [EPC] | 279 | 0.0021 |
| 1 | Provitamin D2 Compound [EPC] | 56 | 0.0019 |
| 2 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 3 | Antidote [EPC] | 88 | 0.0014 |
| 4 | Tetracycline-class Drug [EPC] | 87 | 0.0012 |
| 5 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 5 | 0.0009 |
| 7 | Interleukin-17A Antagonist [EPC] | 31 | 0.0008 |
| 8 | Aminosalicylate [EPC] | 79 | 0.0008 |
| 9 | Angiotensin Converting Enzyme Inhibitor [EPC] | 99 | 0.0007 |